Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia
Clinical trial NCT02244268 · COMPLETED
Trial details
- NCT number
- NCT02244268
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2000-10-01
- Primary completion
- 2001-12-01
- Enrollment
- 3629
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.